HOME Top Market Reports Superdisintegrants Market by Product (Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resins), Application (Tablets, Capsules), Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases) - Global Forecast to 2021

Superdisintegrants Market by Product (Croscarmellose Sodium, Crospovidone, Sodium Starch Glycolate, Ion Exchange Resins), Application (Tablets, Capsules), Therapeutic Area (Oncology, Neurology, Cardiology, Infectious Diseases) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: June 2016
Report Code: PH 4350

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global superdisintegrants market is estimated to grow at a CAGR of 7.8% from 2016 to 2021 to reach USD 416.5 Million by 2021. Factors such as the growing generic drugs market, growing population of geriatric and paediatric patients, and emergence of new superdisintegrants for the pharmaceutical industry are driving the growth of this market.

The growing market in emerging economies has also opened up new avenues for players in the superdisintegrants market. However, factors such as declining R&D expenditures in the development of new superdisintegrants may restrain the growth of this market to a certain extent.

In this report, the superdisintegrants market is segmented on the basis of product type, application, therapeutic area, and geography. On the basis of product type, the market is primarily segmented into natural superdisintegrants, synthetic superdisintegrants, and others. The synthetic superdisintegrants market is further sub-segmented into modified starch, crospovidone, modified cellulose, ion exchange resins, and calcium silicates. The modified cellulose market on the other hand is sub-segmented into croscarmellose sodium and L-HPC. On the basis of application the market is segmented into tablets and capsules. The market by therapeutic area is segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, haematological diseases, and inflammatory diseases.

Geographically, the global superdisintegrants market is segmented into North America, Europe, Asia-Pacific, and Rest of the Word. In 2015, North America accounted for the largest share of the global market, followed by Europe. However, Asia-Pacific region is expected to grow at the highest rate during the forecast period majorly due to the increasing outsourcing of excipient manufacturing to Asian countries, such as India and China.

Some of the prominent players in the global superdisintegrants market include Ashland, Inc. (U.S.), BASF SE (Germany), FMC Corporation (U.S.), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), The Dow Chemical Company (U.S.), Asahi Kasei Corporation (Japan), Nippon Soda Co., Ltd. (Japan), and Huber Corporation (U.S.).

Target Audience

  • Superdisintegrants Manufacturers
  • Superdisintegrants Distributors
  • Pharmaceutical and Biotechnology companies
  • Research Institutes and Academic centres
  • Contract Research Organizations (CROs)
  • Government Associations
  • Market Research and Consulting Firms
  • Venture Capitalists and Investors

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

The global superdisintegrants market includes the following segments:

Global Superdisintegrants Market, by Product Type

  • Natural Superdisintegrants
  • Synthetic Superdisintegrants
    • Modified Starch (Sodium Starch Glycolate)
    • Cross-linked Polyvinylpyrrolidone (crospovidone)
    • Modified Cellulose
  • Croscarmellose-sodium
  • L-Hydroxypropyl Cellulose (L-HPC)
    • Ion Exchange Resins
    • Calcium Silicates
  • Others

Global Superdisintegrants Market, by Application

  • Tablets
  • Capsules

Global Superdisintegrants Market, by Therapeutic Area

  • Gastro-Intestinal Diseases
  • Neurological Diseases
  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Hematological Diseases
  • Inflammatory Diseases

Global Superdisintegrants Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Switzerland
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World
    • Latin America
    • Middle East and Africa

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for the report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of each company

Geographic Analysis

  • Further breakdown of the Rest of Asia-Pacific superdisintegrants market into South Korea, Australia, New Zealand, and others

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 26)

4 Premium Insights (Page No. - 30)
    4.1 Market Overview
    4.2 Asia-Pacific: Market, By Product (2015)
    4.3 Geographic Snapshot of the Market
    4.4 Regional Mix of the Market
    4.5 Market: Developed vs Developing Countries

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Segmentation
           5.2.1 By Product
           5.2.2 By Application
           5.2.3 By Therapeutic Area
    5.3 Key Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 Growing Generics Market
                    5.3.1.2 Growing Population of Geriatric and Pediatric Patients
                    5.3.1.3 Emergence of New Superdisintegrants for the Pharmaceutical Industry
           5.3.2 Restraints
                    5.3.2.1 Declining R&D Investments in Superdisintegrants Development
           5.3.3 Opportunities
                    5.3.3.1 Market Expansion in Emerging Countries
                    5.3.3.2 Rising Healthcare Expenditure
           5.3.4 Challenges
                    5.3.4.1 Quality Concerns Demanding Greater Transparency in Supply Chain
                    5.3.4.2 Formulation of Palatable Odts

6 Industry Insights (Page No. - 43)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Growing Nutraceuticals Market Driving the Demand for Superdisintegrants
           6.2.2 Rising Focus of the Pharmaceutical Industry on Orally Disintegrating Tablets
    6.3 Regulatory Analysis
           6.3.1 North America:
                    6.3.1.1 U.S.
                    6.3.1.2 Canada
           6.3.2 Europe
           6.3.3 APAC
                    6.3.3.1 Japan
                    6.3.3.2 China
                    6.3.3.3 India
    6.4 Porter’s Five Forces Analysis
           6.4.1 Threat of New Entrants
           6.4.2 Threat of Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 Superdisintegrants Market, By Product (Page No. - 51)
    7.1 Introduction
    7.2 Natural Superdisintegrants
    7.3 Synthetic Superdisintegrants
           7.3.1 Modified Starch (Sodium Starch Glycolate)
           7.3.2 Modified Cellulose
                    7.3.2.1 Croscarmellose-Sodium
                    7.3.2.2 Low-Substituted Hydroxypropyl Cellulose (L-HPC)
           7.3.3 Crospovidone
           7.3.4 ION Exchange Resins
           7.3.5 Calcium Silicates
    7.4 Others

8 Superdisintegrants Market, By Application (Page No. - 67)
    8.1 Introduction
    8.2 Tablets
    8.3 Capsules

9 Superdisintegrants Market, By Therapeutic Area (Page No. - 73)
    9.1 Introduction
    9.2 Gastrointestinal Diseases
    9.3 Neurological Diseases
    9.4 Oncology
    9.5 Infectious Diseases
    9.6 Cardiovascular Diseases
    9.7 Hematological Diseases
    9.8 Inflammatory Diseases

10 Geographic Analysis (Page No. - 83)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Switzerland
             10.3.2 Germany
             10.3.3 Italy
             10.3.4 France
             10.3.5 U.K.
             10.3.6 Spain
             10.3.7 Rest of Europe (RoE)
     10.4 Asia-Pacific (APAC)
             10.4.1 Japan
             10.4.2 India
             10.4.3 China
             10.4.4 Rest of Asia-Pacific (RoAPAC)
     10.5 Rest of the World (RoW)
             10.5.1 Latin America
             10.5.2 Middle East and Africa

11 Competitive Landscape (Page No. - 137)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Situation and Trends
             11.3.1 Expansions
             11.3.2 New Product Launches
             11.3.3 Acquisitions
             11.3.4 Collaborations
             11.3.5 Others

12 Company Profiles (Page No. - 145)
(Overview, Financial*, Products & Services, Strategy, and Developments)
     12.1 Introduction
     12.2 Ashland Inc.
     12.3 BASF SE
     12.4 FMC Corporation
     12.5 DFE Pharma
     12.6 JRS Pharma
     12.7 Roquette
     12.8 The DOW Chemical Company
     12.9 Asahi Kasei Corporation
     12.10 Nippon Soda Co., Ltd.
     12.11 Huber Corporation

*Details Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 163)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments
     13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.5 Introducing RT: Real-Time Market Intelligence
     13.6 Available Customizations
     13.7 Related Reports


List of Tables (135 Tables)

Table 1 Market Drivers: Impact Analysis
Table 2 Market Restraints: Impact Analysis
Table 3 Market Opportunities: Impact Analysis
Table 4 Market Challenges: Impact Analysis
Table 5 Global Superdisintegrants Market Size, By Product, 2014 – 2021 (USD Million)
Table 6 Global Market Size, By Country, 2014–2021 (USD Million)
Table 7 Global Natural Superdisintegrants Market Size, By Country, 2014–2021 (USD Million)
Table 8 Global Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 9 Global Synthetic Superdisintegrants Market Size, By Country, 2014–2021 (USD Million)
Table 10 Global Modified Starch Market Size, By Country, 2014–2021 (USD Million)
Table 11 Global Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 12 Global Modified Cellulose Market Size, By Country, 2014–2021 (USD Million)
Table 13 Global Croscarmellose-Sodium Market Size, By Country, 2014–2021 (USD Million)
Table 14 Global L-HPC Market Size, By Country, 2014–2021 (USD Million)
Table 15 Global Crospovidone Market Size, By Country, 2014–2021 (USD Million)
Table 16 Global ION Exchange Resins Market Size, By Country, 2014–2021 (USD Million)
Table 17 Global Calcium Silicates Market Size, By Country, 2014–2021 (USD Million)
Table 18 Global Other Superdisintegrants Market Size, By Country, 2014–2021 (USD Million)
Table 19 Global Market Size, By Application, 2014-2021 (USD Million)
Table 20 Global Market Size for Tablets, By Country, 2014-2021 (USD Million)
Table 21 Global Market Size for Capsules, By Country, 2014-2021 (USD Million)
Table 22 Global Market Size, By Therapeutic Area, 2014–2021 (USD Million)
Table 23 Global Market Size for Gastrointestinal Diseases, By Country, 2014–2021 (USD Million)
Table 24 Global Market Size for Neurological Diseases, By Country, 2014–2021 (USD Million)
Table 25 Global Market Size for Oncology, By Country, 2014–2021 (USD Million)
Table 26 Global Market Size for Infectious Diseases, By Country, 2014–2021 (USD Million)
Table 27 Global Market Size for Cardiovascular Diseases, By Country, 2014–2021 (USD Million)
Table 28 Global Market Size for Hematological Diseases, By Country, 2014–2021 (USD Million)
Table 29 Global Market Size for Inflammatory Diseases, By Country, 2014–2021 (USD Million)
Table 30 Global Market Size, By Region, 2014–2021 (USD Million)
Table 31 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 32 North America: Market Size, By Product, 2014–2021 (USD Million)
Table 33 North America: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 34 North America: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 35 North America: Market Size, By Application, 2014-2021 (USD Million)
Table 36 North America: Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 37 U.S.: Market Size, By Product, 2014–2021 (USD Million)
Table 38 U.S.: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 39 U.S.: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 40 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 41 U.S.: Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 42 Canada: Market Size, By Product, 2014–2021 (USD Million)
Table 43 Canada: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 44 Canada: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 45 Canada: Market Size, By Application, 2014-2021 (USD Million)
Table 46 Canada: Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 47 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 48 Europe: Market Size, By Product, 2014–2021 (USD Million)
Table 49 Europe: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 50 Europe: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 51 Europe: Market Size, By Application, 2014-2021 (USD Million)
Table 52 Europe: Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 53 Switzerland: Market Size, By Product, 2014–2021 (USD Million)
Table 54 Switzerland: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 55 Switzerland: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 56 Switzerland: Market Size, By Application, 2014-2021 (USD Million)
Table 57 Switzerland: Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 58 Germany: Market Size, By Product, 2014–2021 (USD Million)
Table 59 Germany: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 60 Germany: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 61 Germany: Market Size, By Application, 2014-2021 (USD Million)
Table 62 Germany: Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 63 Italy: Market Size, By Product, 2014–2021 (USD Million)
Table 64 Italy: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 65 Italy: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 66 Italy: Market Size, By Application, 2014-2021 (USD Million)
Table 67 Italy: Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 68 France: Market Size, By Product, 2014–2021 (USD Million)
Table 69 France: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 70 France: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 71 France: Market Size, By Application, 2014-2021 (USD Million)
Table 72 France: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 73 U.K.: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 74 U.K.: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 75 U.K.: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 76 U.K.: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 77 U.K.: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 78 Spain: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 79 Spain: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 80 Spain: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 81 Spain: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 82 Spain: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 83 RoE: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 84 RoE: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 85 RoE: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 86 RoE: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 87 RoE: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 88 APAC: Superdisintegrants Market Size, By Country, 2014–2021 (USD Million)
Table 89 APAC: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 90 APAC: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 91 APAC: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 92 APAC: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 93 APAC: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 94 Japan: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 95 Japan: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 96 Japan: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 97 Japan: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 98 Japan: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 99 India: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 100 India: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 101 India: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 102 India: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 103 India: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 104 China: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 105 China: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 106 China: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 107 China: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 108 China: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 109 RoAPAC: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 110 RoAPAC: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 111 RoAPAC: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 112 RoAPAC: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 113 RoAPAC: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 114 RoW: Superdisintegrants Market Size, By Region, 2014–2021 (USD Million)
Table 115 RoW: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 116 RoW: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 117 RoW: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 118 RoW: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 119 RoW: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 120 Latin America: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 121 Latin America: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 122 Latin America: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 123 Latin America: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 124 Latin America: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 125 Middle East and Africa: Superdisintegrants Market Size, By Product, 2014–2021 (USD Million)
Table 126 Middle East and Africa: Synthetic Superdisintegrants Market Size, By Type, 2014–2021 (USD Million)
Table 127 Middle East and Africa: Modified Cellulose Market Size, By Type, 2014–2021 (USD Million)
Table 128 Middle East and Africa: Superdisintegrants Market Size, By Application, 2014-2021 (USD Million)
Table 129 Middle East and Africa: Superdisintegrants Market Size, By Therapeutic Area, 2014-2021 (USD Million)
Table 130 Growth Strategy Matrix, 2013–2016
Table 131 Expansions, 2015 & 2016
Table 132 New Product Launches, 2013–2016
Table 133 Acquisitions, 2015
Table 134 Collaborations, 2014
Table 135 Others, 2015 & 2016


List of Figures (42 Figures)

Figure 1 Superdisintegrants Market
Figure 2 Research Design
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Superidisintegrants Market Size, By Product Type, 2016 vs 2021
Figure 7 Synthetic Superidisintegrants Market Size, By Type, 2016 vs 2021
Figure 8 Superdisintegrants Market Size, By Application, 2016 vs 2021
Figure 9 Superdisintegrants Market Size, By Therapeutic Area, 2016 vs 2021
Figure 10 Asia-Pacific Region to Register Highest Growth During the Forecast Period
Figure 11 Growing Generics Market and Increasing Geriatric Patient Population to Drive Market Growth
Figure 12 Synthetic Superdisintegrants Market Accounted for the Major Share of the Asia-Pacific Superdisintegrants Market
Figure 13 U.S. Commanded the Largest Share of the Superdisintegrants Market in 2015
Figure 14 North America to Dominate the Superdisintegrants Market During the Forecast Period
Figure 15 Developing Markets to Register Higher Growth During the Forecast Period
Figure 16 Superdisintegrants Market Segmentation, By Product
Figure 17 Superdisintegrants Market Segmentation, By Application
Figure 18 Superdisintegrants Market Segmentation, By Therapeutic Area
Figure 19 Superdisintegrants Market: Drivers, Restraints, Opportunities, & Challenges
Figure 20 Demographic Growth Trends of the Elderly Population
Figure 21 Major Trends in the Superdisintegrants Market
Figure 22 Porter’s Five Forces Analysis
Figure 23 Synthetic Superdisintegrants Dominate the Global Superdisintegrants Market
Figure 24 Crospovidone Segment to Register the Highest Growth During the Forecast Period
Figure 25 Tablets Segment to Register Higher Growth During the Forecast Period (2016–2021)
Figure 26 Neurological Diseases Segment Expected to Register the Highest Growth During the Forecast Period
Figure 27 Geographic Snapshot: Markets in Asia-Pacific are Emerging Hotspots
Figure 28 Superdisintegrants Market, By Region, 2015 vs 2021
Figure 29 North America: Superdisintegrants Market Snapshot
Figure 30 Europe: Superdisintegrants Market Snapshot
Figure 31 Asia-Pacific: Superdisintegrants Market Snapshot
Figure 32 Expansions Was the Key Growth Strategy Adopted By Market Players Between 2013 & 2016
Figure 33 Global Superdisintegrants Market Share Analysis, By Key Player, 2015
Figure 34 Battle for Market Share: Expansions Was the Key Strategy Adopted By Prominent Players in the Superdisintegrants Market
Figure 35 Geographic Revenue Mix of the Top Three Players
Figure 36 Company Snapshot: Ashland Inc.
Figure 37 Company Snapshot: BASF SE
Figure 38 Company Snapshot: FMC Corporation
Figure 39 Company Snapshot: Roquette
Figure 40 Company Snapshot: the DOW Chemical Company
Figure 41 Company Snapshot: Asahi Kasei Corporation
Figure 42 Company Snapshot: Nippon Soda Co., Ltd.

The global superdisintegrants market is expected to reach USD 416.5 Million by 2021 from USD 286.8 Million in 2016, at a CAGR of 7.8% during the forecast period of 2016 to 2021. Growing generic drugs market, growing population of geriatric and paediatric patients, and emergence of new superdisintegrants for the pharmaceutical industry are factors driving the growth of the market. However, factors such as declining R&D expenditures in the development of new superdisintegrants may restrain the growth of this market during the forecast period.

In this report, the superdisintegrants market is segmented on the basis of product type, application, therapeutic area, and geography. The product segment is segmented into natural superdisintegrants, synthetic superdisintegrants, and others. The synthetic superdisintegrants market is further sub-segmented into modified starch, crospovidone, modified cellulose, ion exchange resins, and calcium silicates. On the other hand, the market by application includes tablets and capsules. On the basis of therapeutic area, the market is segmented into gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, haematological diseases, and inflammatory diseases.

The synthetic superdisintegrant segment accounted for largest share of the superdisintegrants market in 2015. This is majorly attributed to widespread use of synthetic superdisintegrants in orally and fast disintegrating tablets. Moreover, increasing healthcare awareness and affordability, backed by rising healthcare spending in developing countries, is also expected to contribute to the growth of the superdisintegrants market during the forecast period.

On the basis of regions, the global superdisintegrants market is divided into North America, Europe, Asia-Pacific, and Rest of the World which is further analysed at country levels. The research report also discusses the key market drivers, restraints, challenges, and opportunities in the global market and its sub-markets.

Superdisintegrants Market

In 2015, North America commanded the largest share of the superdisintegrants market, followed by Europe, Asia-Pacific, and Rest of the World. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period, followed by the Rest of the World. Countries such as India, China, and Brazil are expected to offer significant growth opportunities for players operating in this market during the forecast period.

The major players operating in this market include Ashland, Inc. (U.S.), BASF SE (Germany), FMC Corporation (U.S.), JRS Pharma (Germany), DFE Pharma (Germany), Roquette (France), The Dow Chemical Company (U.S.), Asahi Kasei Corporation (Japan), Nippon Soda Co., Ltd. (Japan), and Huber Corporation (U.S.). Expansion was the key strategy adopted by players in the superdisintegrants market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Pharmaceuticals Markets on KnowledgeStore
Request Demo